Ryaltris Spray, Metered
Product Images NDC 68462-659

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Ryaltris (NDC 68462-659). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-d (Figure D)

Black and white photograph illustrating a woman holding a tissue to her nose, suggesting nasal symptom relief. The image is consistent with instructional or promotional content for a nasal spray medication such as Ryaltris.*

FDA Label Image

Figure-f (Figure F)

Illustration showing a woman administering Ryaltris nasal spray. She holds the spray bottle close to her nostril, with one hand pressing the sprayer and the other hand gently holding the nasal passage open. This demonstrates the nasal route and proper use of the metered spray dosage form of Ryaltris.*

FDA Label Image

Figure-g (Figure G)

An illustration showing a woman demonstrating the use of Ryaltris nasal spray. She holds the spray bottle near her nostril with one hand while using the other hand to slightly lift her nose, indicating the proper technique for nasal administration of the metered spray.*

FDA Label Image

Figure-j (Figure J)

Illustration showing a Ryaltris nasal spray bottle with a spray nozzle tip, overlaid by a prohibition sign and text stating "Do not pierce the spray nozzle tip." The image instructs against piercing the nozzle tip of the metered nasal spray.*

FDA Label Image

Figure-m (Figure M)

An image showing a hand rinsing a nasal spray applicator tip under running water from a faucet. The image illustrates cleaning of a metered nasal spray device component.*

FDA Label Image

Figure-a (Figure A)

An exploded view illustration of the Ryaltris metered nasal spray device showing labeled parts including the purple dust cap, spray nozzle unit with spray nozzle tip and finger rest, and the bottle containing the medication. The bottle label indicates Ryaltris nasal spray with active ingredients olopatadine hydrochloride and mometasone furoate.*

FDA Label Image

Figure-b (Figure B)

Ryaltris nasal spray bottle with metered dose spray, containing olopatadine hydrochloride and mometasone furoate. The visible label shows strength as 665 mcg/25 mcg per spray and a net weight of 31g with 240 metered sprays. The labeler is Glenmark Pharmaceuticals Inc., USA.*

FDA Label Image

Figure-c (Figure C)

Ryaltris nasal spray bottle held by a hand, spraying a mist. The label on the white bottle shows the product name Ryaltris, with active ingredients olopatadine hydrochloride and mometasone furoate. The strength is 665 mcg per 25 mcg per spray, with 240 metered sprays in the bottle. The label indicates it is a nasal spray for intranasal use by Glenmark Pharmaceuticals Inc.*

FDA Label Image

Figure-e (Figure E)

Ryaltris nasal spray bottle shown held by a hand. The label displays the active ingredients olopatadine hydrochloride and mometasone furoate with a strength of 665 mcg/25 mcg per spray. The bottle is labeled for intranasal use and contains 240 metered sprays. Manufacturer is Glenmark Pharmaceuticals Inc., USA.*

FDA Label Image

Figure-h (Figure H)

Ryaltris nasal spray packaging label showing a white spray bottle held in hands with a tissue. The label indicates olopatadine hydrochloride and mometasone furoate nasal spray at 665 mcg/25 per spray, containing 240 metered sprays with a net fill weight of 31 g. The label also includes the NDC 68462-659 and the Glenmark Pharmaceuticals Inc. branding.*

FDA Label Image

Figure-i (Figure I)

Photograph of Ryaltris nasal spray bottle being held and having its cap removed, showing label with active ingredients olopatadine hydrochloride and mometasone furoate. The label displays strength as 665 mcg/25 mg per spray and indicates 240 metered sprays with 31 g net fill weight. The labeler is Glenmark Pharmaceuticals Inc., USA.*

FDA Label Image

Figure-k (Figure K)

Ryaltris nasal spray metered spray bottle held by hands showing the label with active ingredients olopatadine hydrochloride and mometasone furoate. The label indicates a strength of 665 mcg/25 (units partially obscured), with a net fill weight of 31 g and 240 metered sprays per bottle. The product is labeled by Glenmark Pharmaceuticals Inc., USA.*

FDA Label Image

Figure-l (Figure L)

Ryaltris nasal spray bottle showing the product name and the active ingredients olopatadine hydrochloride and mometasone furoate. The label indicates a dosage strength of 665 mcg/25 mcg per spray with 240 metered sprays in the 31 g net fill bottle. The bottle is displayed next to a sideways plastic measuring cup and has a separate black cap beside it. Labeler is Glenmark Pharmaceuticals Inc., USA.*

FDA Label Image

Figure-n (Figure N)

The image shows a person holding a white nasal spray bottle labeled Ryaltris. The label indicates the active ingredients olopatadine hydrochloride and mometasone furoate. The spray delivers 665 mcg per 25 mL dose. The metered spray bottle is designed for nasal administration and contains 31 g net weight of solution. The label also references Glenmark Pharmaceuticals Inc., USA as the labeler.*

FDA Label Image

Glenmarklogo (Glenmarklogo)

FDA Label Image

Glenmarklogo2 (Glenmarklogo2)

FDA Label Image

Image1 (Image1)

Label for Ryaltris nasal spray, containing olopatadine hydrochloride and mometasone furoate with a strength of 665 mcg/25 mcg per spray. The label states it is a metered nasal spray with 240 sprays per container, distributed by Glenmark Pharmaceuticals Inc., USA, and produced in India. Instructions include priming and storage details.*

FDA Label Image

Image2 (Image2)

Packaging label for Ryaltris nasal spray containing olopatadine hydrochloride and mometasone furoate. The label shows strengths of 665 mcg/25 mcg per spray, with 240 metered sprays in a 31 g net fill weight bottle. The labeler is Glenmark Pharmaceuticals Inc., USA. The label includes usage instructions, storage information, and the NDC 68462-659-27.*

FDA Label Image

Structuremometasone (Structuremometasone)

Chemical structure of the active ingredient mometasone furoate, shown as a detailed molecular diagram with atoms and bonds, including a chlorine atom (Cl) and a water molecule (H2O) indicated.*

FDA Label Image

Structureolopatadine (Structureolopatadine)

Chemical structure diagram of olopatadine hydrochloride, one of the active ingredients in Ryaltris nasal spray. The diagram shows the molecular arrangement including rings and functional groups with a hydrochloride (HCl) indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.